Concepedia

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

Esaú João, R. L. Morrison, David E. Shapiro, Nahida Chakhtoura, Maria Isabel S. Gouvea, Maria de Lourdes Benamor Teixeira, Trevon Fuller, Blandina T. Mmbaga, James S. Ngocho, Boniface Njau,

The Lancet HIV · 2020 · 46 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Jeffrey L. Lennox, Edwin DeJesus, Adriano Lazzarin et al. · The Lancet · 2009 · 620 citations

, , +16

The randomization and stratification of patients to clinical trials

Marvin Zelen · Journal of Chronic Diseases · 1974 · 614 citations

, , +10

No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception

Laurent Mandelbrot, Roland Tubiana, Jérôme Le Chenadec et al. · Clinical Infectious Diseases · 2015 · 307 citations · Full text

, , +17

Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection

Karin Nielsen‐Saines, D. Heather Watts, Valdiléa G. Veloso et al. · New England Journal of Medicine · 2012 · 235 citations · Full text

, , +15

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

Rebecca Zash, Denise L. Jacobson, Modiegi Diseko et al. · The Lancet Global Health · 2018 · 151 citations · Full text

, , +15